Caris Life Sciences vs Deep Genomics
Caris Life Sciences vs Deep Genomics, compared side by side on 19 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Caris Life Sciences is on 59/100 and Deep Genomics on 61/100.
Where each one leads
Caris Life Sciences
- agent readiness: 47/100 against 35/100
- domain rating: 63/100 against 54/100
- headcount: 1,659 against 110
- funding raised: $700M against $241M
- LinkedIn following: 77,698 against 30,891
Deep Genomics
Leads on none of the measures we hold for both companies.
At a glance
| Measure | Caris Life Sciences | Deep Genomics |
|---|---|---|
| What it is | Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling. | AI-powered biotechnology company developing RNA therapeutics for genetic diseases. |
| Category | Biotech, MedTech, HealthTech, Genomics | Biotech, Drug Discovery, Genomics, AI-Driven Drug Discovery |
| Sells toBusiness model | B2B | B2B |
| Offering | Services | Platform |
| Founded | 2008 | 2015 |
| Headquarters | Irving, United States | Toronto, Canada |
| Status | Active | Active |
Size, funding and growth
| Measure | Caris Life Sciences | Deep Genomics |
|---|---|---|
| Employees | 1,659 | 110 |
| Headcount growthLast 12 months | Not published | +19.3% |
| Total funding | $700M | $241M |
| Latest round | Series D | Series C |
| Valuation | $7.8B | Not published |
| LinkedIn followers | 77,698 | 30,891 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Caris Life Sciences | Deep Genomics |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 59/100 | 61/100 |
| Traction | 60/100 | 60/100 |
| Team | Not published | 60/100 |
| Search visibility | 22/100 | 33/100 |
| Quality | 78/100 | 68/100 |
| Agent readinessHow well an AI agent can read and act on the site | D (47/100) | F (35/100) |
| Domain ratingLink authority, 0-100 | 63/100 | 54/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Caris Life Sciences | Deep Genomics |
|---|---|---|
| Hosting | Self Managed | Self Managed |
| CMS | WordPress | Not detected |
| Analytics | Google Tag Manager | Google Analytics 4, Segment |
Caris Life Sciences vs Deep Genomics: common questions
Which is better, Caris Life Sciences or Deep Genomics?
On our 0-100 score Deep Genomics rates higher (61/100 against 59/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 19 data points above: read the rows that match what you are buying for.
How do Caris Life Sciences and Deep Genomics compare on the numbers?
Caris Life Sciences leads on agent readiness (47/100 against 35/100), domain rating (63/100 against 54/100), headcount (1,659 against 110), funding raised ($700M against $241M), LinkedIn following (77,698 against 30,891).
Read the full Caris Life Sciences review and pricing or the Deep Genomics review and pricing. You can also browse other Caris Life Sciences alternatives we track.